Premium
Endstage renal failure in diabetes type II ‐ a silent epidemic
Author(s) -
RITZ Eberhard,
MILTENBERGERMILTENGERMILTENYI Gabriel,
RYCHLIK Ivan,
FLISER Danilo
Publication year - 1998
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/j.1440-1797.1998.tb00363.x
Subject(s) - medicine , diabetes mellitus , incidence (geometry) , diabetic nephropathy , renal replacement therapy , population , type 2 diabetes , intensive care medicine , nephropathy , pediatrics , endocrinology , environmental health , physics , optics
SUMMARY: Endstage renal failure in patients with type II diabetes has become, or will become, the leading cause of endstage renal failure in different countries with Western life style. the incidence of the proportion of patients with diabetes mellitus, mostly type II, amongst patients admitted for renal replacement therapy, is continuously on the rise, and somewhat less so the prevalence of diabetic patients on renal replacement therapy. the discrepancy is due to the higher mortality in diabetic patients as compared to non‐diabetic patients. the causes for the increase comprises of increasing prevalence of type II diabetes in the population, better survival in diabetic patients with nephropathy, and other factors. Efforts to stem this medical catastrophy will necessitate (i) information of the medical community: about the renal risk of type II diabetes and the striking effectiveness of preventive measures, (ii) implementation of better care of the diabetic patient, and (iii) efforts to reduce the high prevalence of diabetes in the population.